Your browser doesn't support javascript.
loading
VEGF-Related Germinal Polymorphisms May Identify a Subgroup of Breast Cancer Patients with Favorable Outcome under Bevacizumab-Based Therapy-A Message from COMET, a French Unicancer Multicentric Study.
Gal, Jocelyn; Milano, Gérard; Brest, Patrick; Ebran, Nathalie; Gilhodes, Julia; Llorca, Laurence; Dubot, Coraline; Romieu, Gilles; Desmoulins, Isabelle; Brain, Etienne; Goncalves, Anthony; Ferrero, Jean-Marc; Cottu, Paul-Henri; Debled, Marc; Tredan, Olivier; Chamorey, Emmanuel; Merlano, Marco Carlo; Lemonnier, Jérôme; Etienne-Grimaldi, Marie-Christine; Pierga, Jean-Yves.
Afiliación
  • Gal J; Epidemiology and Biostatistics Department, Centre Antoine Lacassagne, University Côte d'Azur, 06100 Nice, France.
  • Milano G; Cancer Pharmacogenetics and Radiogenetics Unit (UPRC) 7497, Centre Antoine Lacassagne, University Côte d'Azur, 33 avenue de Valombrose, 06100 Nice, France.
  • Brest P; Scientific Research National Center (CNRS), Inserm, Ircan, FHU-Oncoage, Centre Antoine Lacassagne, University Côte d'Azur, 06100 Nice, France.
  • Ebran N; Oncopharmacology Unit, Centre Antoine Lacassagne, University Côte d'Azur, 06100 Nice, France.
  • Gilhodes J; Department of Biostatistics, Institut Claudius Regaud, IUCT Oncopole, 31300 Toulouse, France.
  • Llorca L; Oncopharmacology Unit, Centre Antoine Lacassagne, University Côte d'Azur, 06100 Nice, France.
  • Dubot C; Medical Oncology Department, Institut Curie, St Cloud, 92210 Paris, France.
  • Romieu G; Medical Oncology Department, Centre Val d'Aurelle-Paul Lamarque, 34298 Montpellier, France.
  • Desmoulins I; Medical Oncology Department, Centre Georges François Leclerc, 2100 Dijon, France.
  • Brain E; Medical Oncology Department, Institut Curie, St Cloud, 92210 Paris, France.
  • Goncalves A; Medical Oncology Department, Institut Paoli-Calmettes, 13900 Marseille, France.
  • Ferrero JM; Medical Oncology Department, Centre Antoine Lacassagne, University Côte d'Azur, 06100 Nice, France.
  • Cottu PH; Medical Oncology Department, Institut Curie, St Cloud, 92210 Paris, France.
  • Debled M; Medical Oncology Department, Institut Bergonie, 33000 Bordeaux, France.
  • Tredan O; Medical Oncology Department, Centre Leon Berard, 69008 Lyon, France.
  • Chamorey E; Epidemiology and Biostatistics Department, Centre Antoine Lacassagne, University Côte d'Azur, 06100 Nice, France.
  • Merlano MC; Oncology Department, S. Croce & Carle Teaching Hospital, 12100 Cuneo, Italy.
  • Lemonnier J; Research & Development Departement, Unicancer, 94270 Paris, France.
  • Etienne-Grimaldi MC; Oncopharmacology Unit, Centre Antoine Lacassagne, University Côte d'Azur, 06100 Nice, France.
  • Pierga JY; Medical Oncology Department, Institut Curie, St Cloud, 92210 Paris, France.
Pharmaceuticals (Basel) ; 13(11)2020 Nov 23.
Article en En | MEDLINE | ID: mdl-33238394
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Pharmaceuticals (Basel) Año: 2020 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Pharmaceuticals (Basel) Año: 2020 Tipo del documento: Article País de afiliación: Francia